It is a pharma private limited company based in Delhi, Delhi, India, established in 2012.
2012 | Delhi, Delhi, India | ActiveAmazone Pharmaceuticals Private Limited, a active private limited company, was established on 16 January 2012 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U33110DL2012PTC230027. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Shweta Parekh (Director), Abhishek Gupta (Additional Director), Abhishek Parekh (Additional Director). Past directors included Chetna Gupta. It holds ₹5.70 M open charges and ₹1.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at G-216, Hall No. 2, Ground Floor Dhakka Village, Near Kingsway Camp,, Delhi, Delhi, 110009.
U33110DL2012PTC230027
230027
16 January 2012
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Amazone Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shweta Parekh | Director | 16 Jan 2012 | Current |
| Abhishek Gupta | Additional Director | 28 Apr 2016 | Current |
| Abhishek Parekh | Additional Director | 28 Apr 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Oct 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amazone Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.38% increase. The company also saw a substantial improvement in profitability, with a 15.9% increase in profit. The company's net worth Soared by an impressive increase of 44.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Amazone Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,700,000.00
₹1,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2025 | Canara Bank | ₹1.70 M | Open |
| 16 Sep 2020 | Canara Bank | ₹4.00 M | Open |
| 10 Aug 2017 | Canara Bank | ₹1.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Amazone Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Amazone Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amazone Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Amazone Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Amazone Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
A charge with Canara Bank amounted to Rs. 1.70 M with Charge ID 101070490 was registered on 29 Mar 2025. was recorded as a recent event.
A charge with Canara Bank of Rs. 4.00 M registered on 16 Sep 2020 with Charge ID 100372153 was modified on 05 Nov 2024. was recorded as a recent event.
Progress on A charge registered on 10 Aug 2017 via Charge ID 100120770 with Canara Bank was fully satisfied on 28 Sep 2020. was documented.
The activity A charge with Canara Bank amounted to Rs. 4.00 M with Charge ID 100372153 was registered on 16 Sep 2020. was completed.
The CIN of Amazone Pharmaceuticals Private Limited is U33110DL2012PTC230027.
Amazone Pharmaceuticals Private Limited is headquartered at G-216, Hall No. 2, Ground Floor Dhakka Village, Near Kingsway Camp,, Delhi, Delhi, 110009.
Amazone Pharmaceuticals Private Limited was incorporated on 16 January 2012.
The current directors of Amazone Pharmaceuticals Private Limited are
The primary industry of Amazone Pharmaceuticals Private Limited is Trade.
Amazone Pharmaceuticals Private Limited is unlisted.
The authorized capital of Amazone Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Amazone Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX